Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent studies in bladder cancer

H Ozen1

  • 1Hacettepe University, Ankara, Turkey.

Current Opinion in Oncology
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Routine random biopsies do not improve bladder cancer outcomes and should be abandoned. Molecular genetic analysis offers promise for improved bladder carcinoma survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new adjacent tool in the management of clinical T1a solid renal masses.

Actas urologicas espanolas·2026
Same author

Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation.

International journal of laboratory hematology·2016
Same author

Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency.

Bone marrow transplantation·2015
Same author

Is routine stenting necessary in pyeloplasty?

Pediatric surgery international·2013
Same author

Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?

Indian journal of urology : IJU : journal of the Urological Society of India·2010
Same author

Pathological, biochemical and haematological investigations on the protective effect of alpha-lipoic acid in experimental aflatoxin toxicosis in chicks.

British poultry science·2010
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Molecular Biology

Background:

  • Bladder carcinoma progression involves p53 overexpression and chromosome 9 loss of heterozygosity.
  • Predicting prognosis and guiding therapy for bladder cancer requires refined methods.

Purpose of the Study:

  • To evaluate the utility of routine random biopsies in bladder cancer management.
  • To assess the impact of radical cystectomy and chemotherapy on patient survival.
  • To explore the role of molecular genetics in improving bladder cancer prognostication.

Main Methods:

  • Analysis of a well-designed trial involving 1745 bladder cancer patients.
  • Review of survival data for patients undergoing radical cystectomy.
  • Consideration of neoadjuvant and adjuvant chemotherapy protocols.

Related Experiment Videos

  • Exploration of molecular genetic markers for prognostic assessment.

    • Main Results:

    • Routine random biopsies offered minimal improvement in recurrence and progression rates at the cost of increased intravesical therapy.
    • Primary tumor stage significantly impacted survival in radical cystectomy patients, even with positive nodes.
    • Radical cystectomy and lymph node dissection showed benefit in node-positive patients with tumors confined to the bladder.
    • Neoadjuvant chemotherapy and bladder preservation are suitable for select patients with significant tumor reduction.
    • Adjuvant chemotherapy response can be enhanced by consolidation surgery in responders.

    Conclusions:

    • Routine random biopsies are not recommended for bladder cancer prognosis or guiding adjuvant therapy.
    • Radical cystectomy and lymph node dissection are effective for certain node-positive bladder cancer cases.
    • Chemotherapy regimens, including neoadjuvant and adjuvant approaches, can be optimized for specific patient groups.
    • Molecular genetic analysis holds potential for enhancing prognostic accuracy and improving bladder carcinoma survival trends.